Options for a Second-Line Antiretroviral Regimen for HIV Type 1-Infected Patients Whose Initial Regimen of a Fixed-Dose Combination of Stavudine, Lamivudine, and Nevirapine Fails

MLA

Weerawat Manosuth, et al. “Options for a Second-Line Antiretroviral Regimen for HIV Type 1-Infected Patients Whose Initial Regimen of a Fixed-Dose Combination of Stavudine, Lamivudine, and Nevirapine Fails.” Clinical Infectious Diseases, vol. 44, Feb. 2007, pp. 447–52. EBSCOhost, https://doi.org/10.1086/510745.

APA

Weerawat Manosuth, Sasisopin Kiertiburanakul, Wasun Chantratita, Bucha Piyavong, Somnuek Sungkanuparph, & Noppanath Chumpathat. (2007). Options for a Second-Line Antiretroviral Regimen for HIV Type 1-Infected Patients Whose Initial Regimen of a Fixed-Dose Combination of Stavudine, Lamivudine, and Nevirapine Fails. Clinical Infectious Diseases, 44, 447–452. https://doi.org/10.1086/510745

Chicago

Weerawat Manosuth, Sasisopin Kiertiburanakul, Wasun Chantratita, Bucha Piyavong, Somnuek Sungkanuparph, and Noppanath Chumpathat. 2007. “Options for a Second-Line Antiretroviral Regimen for HIV Type 1-Infected Patients Whose Initial Regimen of a Fixed-Dose Combination of Stavudine, Lamivudine, and Nevirapine Fails.” Clinical Infectious Diseases 44 (February): 447–52. doi:10.1086/510745.